John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...

Today, the Biotechnology Innovation Organization (BIO) released a new report, " The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases," examining the latest ...

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic ...

The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The new report, The U.S ...

Current pipeline “insufficient” to meet the threat of AMR, policy reforms critically needed The Biotechnology Innovation Organization (BIO) today released a new report examining antibacterial ...

BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry ...

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

Democratic lawmakers in the U.S. Senate advanced drug pricing legislation today that would drastically alter the Medicare program. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology ...

The following statement may be attributed to Nancy Travis, vice president of international affairs, BIO. “The Biotechnology Innovation Organization supports today’s action by the Office of the U.S.

The Biotechnology Innovation Organization (BIO) released an updated report produced in partnership with the International Council of Biotechnology Associations (ICBA) that highlights biotechnology’s ...

The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace ...